[Expression and localization of ArgBP2 in osteosarcoma MG-63 cells]

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• Osteosarcoma is a primary bone cancer with limited treatment options.
• Understanding the role of specific proteins like human ArgBP2 (hArgBP2) in cancer cells is crucial for developing targeted therapies.

Purpose of the Study:

• To construct an eukaryotic expression vector for GFP-tagged human ArgBP2 (GFP-hArgBP2).
• To investigate the expression and subcellular localization of hArgBP2 in MG-63 osteosarcoma cells.

Main Methods:

• Polymerase chain reaction (PCR) amplification of the hArgBP2 coding sequence.
• Cloning into the pEGFP-C1 eukaryotic expression vector.
• Transfection into MG-63 cells, followed by Western blot, laser scanning confocal microscopy, and immunoprecipitation.

Main Results:

• Successful construction of the GFP-hArgBP2 expression vector.
• Detection of GFP-hArgBP2 fusion protein (97 kDa) expression in MG-63 cells via Western blot.
• Localization of GFP-hArgBP2 primarily in the cytoplasm and perinuclear regions.

Conclusions:

• The recombinant plasmid for hArgBP2 expression was successfully generated.
• Expression and successful immunoprecipitation of the GFP-hArgBP2 fusion protein were confirmed.
• GFP-hArgBP2 exhibits significant localization in the cytoplasm and perinucleus of osteosarcoma cells.